| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Recruiting | Alzheimer's Disease Genetics Study | ||||
| Conditions: | Alzheimer Disease; Late Onset Alzheimer Disease | |||||
| Intervention: | ||||||
| 2 | Recruiting | Clinical Trial on Alzheimer Disease, Presbycusis and Hearing Aids | ||||
| Conditions: | Alzheimer Disease; Presbycusis | |||||
| Intervention: | Device: Hearing aids used : PHONAK Savia and Valeo | |||||
| 3 | Recruiting | Effects of Estrogen on Memory in Post-Menopausal Women and Patients With Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: Donepezil; Drug: Estrogen; Drug: Progesterone | |||||
| 4 | Recruiting | Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Drug: memantine | |||||
| 5 | Not yet recruiting | Pilot Study of the Effects of Resveratrol Supplement in Mild-to-Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Dietary Supplement: Longevinex brand resveratrol supplement; Dietary Supplement: placebo | |||||
| 6 | Recruiting | Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease | ||||
| Conditions: | Alzheimer Disease; Sleep Initiation and Maintenance Disorders | |||||
| Interventions: | Behavioral: Walking Program; Behavioral: Light Exposure Program; Behavioral: Combined Education, Walking and Light Exposure Program; Behavioral: Routine Medical Care with Education | |||||
| 7 | Recruiting | Anti-Psychotic Discontinuation in Alzheimer's Disease | ||||
| Conditions: | Alzheimer Disease; Psychotic Disorders | |||||
| Intervention: | Drug: risperidone | |||||
| 8 | Recruiting | Bathing Persons With Alzheimer's Disease aT Home (The BATH Study) | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Behavioral: Caregiver reminiscence with coaching | |||||
| 9 | Recruiting | Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: alphatocopherol; Drug: Selenium; Drug: Placebo replacement for vitamin E; Drug: Placebo replacement for Selenium | |||||
| 10 | Recruiting | Comparative Efficacy, Safety, and Tolerability of Rivastigmine 10 and 15 cm2 Patch in Patients With Alzheimer's Disease (AD) Showing Cognitive Decline | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Drug: Rivastigmine transdermal patch | |||||
| 11 | Recruiting | A Double-Blind, Placebo-Controlled, 2-Year Study of Galantamine Used to Treat Patients With Mild to Moderate Alzheimer's Disease. | ||||
| Conditions: | Dementia, Alzheimer Type; Alzheimer Disease | |||||
| Interventions: | Drug: Galantamine; Drug: Placebo | |||||
| 12 | Recruiting | A Study of V950 in People With Alzheimer Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Biological: V950; Biological: Comparator: ISCOMATRIX™ | |||||
| 13 | Recruiting | Delaying the Progression of Driving Impairment in Individuals With Mild Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Drug: Memantine | |||||
| 14 | Recruiting | A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease. | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Drug: R1450 | |||||
| 15 | Recruiting | MRI of Alzheimer's Disease Imaging Amyloid Plaques in Persons With and Without Memory Problems | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | ||||||
| 16 | Recruiting | Memantine for Agitation and Aggression in Severe Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Drug: memantine | |||||
| 17 | Recruiting | Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: bapineuzumab; Other: placebo | |||||
| 18 | Recruiting | Study Evaluating the Efficacy and Safety of Bapineuzumab in Alzheimer Disease Patients | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: bapineuzumab; Drug: placebo | |||||
| 19 | Recruiting | Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With Parkinson Disease or Alzheimer Disease and in Healthy Subjects | ||||
| Conditions: | Parkinson Disease; Alzheimer Disease | |||||
| Intervention: | Procedure: SPECT scan | |||||
| 20 | Recruiting | Deep Brain Stimulation (DBS) for Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Procedure: Deep Brain Stimulation (Fornix DBS) | |||||
| 21 | Recruiting | Evaluation of [123I] MNI-330 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Radiation: MNI-330 as a brain SPECT tracer of Beta-Amyloid | |||||
| 22 | Recruiting | Biomarkers and Early Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | ||||||
| 23 | Recruiting | Home Safety Clinical Trial for Alzheimer's Disease | ||||
| Conditions: | Alzheimer's Disease; Dementia | |||||
| Intervention: | Behavioral: Home Safety Toolkit | |||||
| 24 | Recruiting | Couples Coping With Alzheimer's Disease | ||||
| Conditions: | Aging; Alzheimer Disease; Dementia | |||||
| Intervention: | Behavioral: Information, counseling and support | |||||
| 25 | Not yet recruiting | Progression Delaying Effect of Escitalopram in Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: escitalopram; Drug: placebo | |||||
| 26 | Recruiting | Exercise Treatment of Mild-Stage Probable Alzheimer's Disease | ||||
| Conditions: | Alzheimer Disease; Memory Disorders; Dementia | |||||
| Intervention: | Behavioral: Participation in a monitored exercise program | |||||
| 27 | Recruiting | Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease | ||||
| Conditions: | Alzheimer's Disease; Glaucoma | |||||
| Intervention: | ||||||
| 28 | Recruiting | Randomized Trial of a Nutritional Supplement in Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Dietary Supplement: Resveratrol with Glucose, and Malate; Dietary Supplement: Placebo | |||||
| 29 | Recruiting | An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Behavioral: Information, counseling and support | |||||
| 30 | Not yet recruiting | Efficacy Assessment of Three Non Pharmacological Therapies in Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Behavioral: Standard intervention protocol; Behavioral: Standard intervention protocol + Cognitive training therapy; Behavioral: Standard intervention protocol + Reminiscence therapy; Behavioral: Standard intervention protocol + "Made-to-measure" program | |||||
| 31 | Not yet recruiting | Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: SB-742457; Drug: Donepezil; Drug: Placebo | |||||
| 32 | Recruiting | A Pilot Study of Inflammatory Markers in Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: doxycycline; Drug: rifampin; Drug: placebo | |||||
| 33 | Recruiting | Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: ZT-1; Drug: Donepezil | |||||
| 34 | Recruiting | Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: T-817MA; Drug: Placebo | |||||
| 35 | Recruiting | ELND005 in Patients With Mild to Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: ELND005; Drug: Placebo Control; Drug: ELND005; Drug: ELND005 | |||||
| 36 | Not yet recruiting | Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: Bryostatin for Injection; Drug: Placebo | |||||
| 37 | Recruiting | Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Drug: rosiglitazone maleate | |||||
| 38 | Recruiting | Safety and Cognitive Function Study of EVP-6124 in Patients With Alzheimer's Disease | ||||
| Conditions: | Alzheimer's Disease; Central Nervous System Diseases | |||||
| Interventions: | Drug: EVP-6124; Drug: placebo | |||||
| 39 | Recruiting | Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone | ||||
| Conditions: | Alzheimer's Disease; Hypogonadism | |||||
| Intervention: | Drug: Testosterone replacement therapy: AndroGel 1% 5g packets (Solvay Pharmaceuticals) | |||||
| 40 | Recruiting | A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: dl-alpha-tocopherol; Drug: Memantine; Drug: Placebo | |||||
| 41 | Recruiting | System-IGF-1 Pathway and Alzheimer's Disease | ||||
| Conditions: | Alzheimer's Disease; Mild Cognitive Impairment; Control With Normal Cognitive Function; Control With Normal Activities of Daily Living. | |||||
| Intervention: | ||||||
| 42 | Recruiting | Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Biological: PF-04360365 10 mg/kg; Biological: PF-04360365 1 mg/kg; Biological: PF-04360365 3 mg/kg; Biological: PF-04360365 5 mg/kg | |||||
| 43 | Recruiting | Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Interventions: | Drug: Placebo; Drug: PAZ-417 | |||||
| 44 | Recruiting | Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease | ||||
| Condition: | Alzheimer Disease | |||||
| Intervention: | Drug: bapineuzumab | |||||
| 45 | Not yet recruiting | Phase 2, Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Biological: PF-04360365 0.1 mg/kg; Biological: PF-04360365 0.5 mg/kg; Biological: PF-04360365 1 mg/kg; Drug: Placebo | |||||
| 46 | Recruiting | A Study to Evaluate dASL Imaging as a Biomarker for Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Other: dASL imaging | |||||
| 47 | Recruiting | Clinical Effectiveness of 10 cm2 Rivastigmine Patch in Patients With Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Drug: Rivastigmine | |||||
| 48 | Not yet recruiting | Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Interventions: | Drug: Varenicline; Drug: Placebo | |||||
| 49 | Recruiting | Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | Drug: Aricept (donepezil SR) | |||||
| 50 | Recruiting | Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interaction™ Test | ||||
| Condition: | Alzheimer's Disease | |||||
| Intervention: | ||||||
| Studies Shown (1-50) | Next (51-100) |  |
|
